Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:998 (30 October), doi:10.1136/bmj.329.7473.998
Melissa Sweet
Sydney
| The first 150 words of the full text of this article appear below. |
A radical new approach to paying drug companies should be introducedrewarding them for improving health rather than maximising sales, the UK parliamentary health committee has been told.
The proposal, by Healthy Skepticism, an international watchdog group based in Australia that is concerned with misleading drug marketing, was put to committee members during a week long visit to Australia that ended last week.
The MPs met doctors, academics, and drug companies and other groups as part of their inquiry into the influence of the drug industry. They also held meetings related to previous inquiries into child migrants and HIV and AIDS.
Dr Peter Mansfield, director of Healthy Skepticism, said in a memorandum given to the MPs that doctors and drug companies were locked in a "vicious circle," encouraging each other to do the wrong thing.
"If companies overpromote their drugs effectively, doctors reward them via higher drug sales," he said. "If
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses